News

Cell culture media are growth substances and nutrients for cells or microorganisms, required in every biopharmaceutical manufacturing process. As part of the agreement, SSB will sell and market

The supplemental new drug application (sNDA) submitted to the FDA adds the company’s goal of expanding the Vascepa manufacturing supply chain. Amarin chairman and chief executive officer Joseph

The company, based at Stevenage Bioscience Catalyst, UK, raised £11.5m in Series A financing to advance the molecules into clinical studies. Funding will primarily be focused on the

The collaboration, planned for three years, will leverage GlycoVaxyn’s bio-conjugation technology in developing vaccines against a range of undisclosed bacterial pathogens. GlycoVaxyn co-founder and chief scientific officer Michael

The mobile application enables clients to search the company’s more than 1000 bioanalytical assays from an iPhone, iPad, or Android Smartphone. PharmaNet/i3 business development executive director Farah Ahmad

Three-dimensional human tissues or models are designed for use in the medical research, drug discovery and development. Organovo chairman and chief executive officer Keith Murphy said, "This relationship

The double-blind study demonstrated considerable boost in the intestinal flora of the infants such as Lactobacilli and Bifidobacteria, when fed with InFat. Multicenter study designed to assess the

Developed by MyoRX, the topical solution cream leverages the lipophilic properties of omega-3 fatty acids in combination with aspirin to create a medical delivery mechanism with minimal side

UMEC/VI is a combination of two investigational bronchodilator molecules, GSK573719 or UMEC, a long-acting muscarinic antagonist (LAMA) and vilanterol, a long-acting beta2 agonist (LABA), administered using the ELLIPTA